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GERALDINE FERRARO TO RECEIVE
ASBMT PUBLIC SERVICE AWARD AT
TANDEM BMT MEETINGS
Geraldine Ferraro, former member
of Congress, Democratic vice presiden-
tial nominee in 1984, and former U.N.
ambassador, has been chosen to re-
ceive the 2003 ASBMT Public Service
Award. She will be honored for her
accomplishments in bringing national
attention to blood cancers, the need
for medical research funding and the
importance of reducing the time it
takes to develop and launch new
blood cancer treatments.
Her efforts were key in the enact-
ment of the Hematological Cancer Re-
search Investment and Education Act,
signed into law last May. The new leg-
islation coordinates federal support
and authorizes $275 million in new
expenditures for blood cancer research
and education programs.
Ms. Ferraro has personal experi-
ence with multiple myeloma, discov-
ered during a routine physical exami-
nation in 1998. She created national
news when she opted for a treatment
that combines infusions of bone-
strengthening bisphosphonates and
thalidomide, which was pulled from
global markets after being linked to se-
rious birth defects in the late 1950s and
1960s.
Like most of the 14,000 people di-
agnosed with multiple myeloma each
year in the United States, Ms. Ferraro
had no history of the disease in her
family, and no apparent risk factors.
Together with her physician, Kenneth
Anderson, M.D., of Dana-Farber Can-
cer Institute, she has testified before
Congress about her illness and its treat-
ment to encourage passage of the he-
matological research and education
act.
A recipient for the ASBMT Public
Service Award is determined each year
by the society’s officers and executive
committee. The award will be pre-
sented at the Tandem BMT Meetings,
Jan. 30-Feb. 3 in Keystone, Colo.
SESSION EXPLORES STEM CELLS
AND TISSUE REGENERATION
New developments in tissue regen-
eration will be explored in a plenary
session on Monday afternoon, Feb. 3,
during the 2003 Tandem BMT Meet-
ings in Keystone, Colo. Chaired by
ASBMT Vice President Armand Keating,
MD, the plenary session will begin with
a review of the hematopoietic and
marrow stromal cell types under inves-
tigation.
“Other presentations will focus on
regeneration of skeletal muscle and
neural tissue in a variety of pre-clinical
models,” he said. “Clinical data also will
be presented on patients treated by
intracoronary infusion of hematopoi-
etic stem cells after myocardial infarc-
tion.” Included in the lineup of topics
and speakers are:
● Adult Stem Cell Plasticity: A Physio-
logic Repair Mechanism—Tim Bra-
zelton, MD
● Bone Marrow Cells to Repair the
Injured Spinal Cord—Jeffrey Kocsis,
MD
● A Clinical Trial of Intracoronary Stem
Cell Transplants to Regenerate the
Myocardium After Myocardial In-
farction—Peter Wernet, MD
WORKSHOP EXAMINES ISSUES
OF BIODEFENSE AND BMT
“Terrorism—Is the Transplant Com-
munity Prepared?” is the provocative
question and title of a workshop that
will be held on the final day of the
2003 Tandem BMT Meetings, Feb. 3,
in Keystone, Colo.
A so-called “dirty nuclear bomb”
could cause exposure to penetrating
radiation well beyond the immediate
radius of the fireball and air blast. “A
blast in a densely populated urban
area could result in tens of thousands
exposed to between 5 and 15 Gy of
whole-body penetrating radiation—
doses at which the primary acute tox-
icities are hematopoietic and gastroin-
testinal,” said Dennis Confer, MD, who
will chair the workshop on biodefense.
For the past 11 years, Dr. Confer has
been medical director of the National
Marrow Donor Program.
“Aggressive medical support could
significantly improve outcomes,” he
said. “Allogeneic hematopoietic stem
cell transplantation could be an impor-
tant supportive measure.”
Recent improvements in support-
ive care and the evolution and growth
of the medical infrastructure support-
ing allogeneic transplant units make it
rational to consider national and re-
gional emergency preparedness plan-
ning in the event of a nuclear strike, Dr.
Confer said.
SYMPOSIUM ON ADVANCES
IN STEM CELL TRANSPLANTATION
WILL BE HELD IN SAN DIEGO
The 11th International Symposium
on Recent Advances in Stem Cell Trans-
plantation will be held May 8-10 in San
Diego.
Initiated at the University of Califor-
nia-San Diego in 1992, the annual
symposium is held alternately in San
Diego and Heidelberg. The speakers
are leaders in their respective disci-
plines and will present up-to-the
minute information about stem cell
transplantation. A special session has
been allocated for presentation of the
best abstracts submitted for the confer-
ence. Information is available at
cme.ucsd.edu/stemcell/index.htm.
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